WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Plitidepsin

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.

    DOI: 10.1016/j.mam.2025.101412

    Source identity and connection checked by Codex (AI).

  2. Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19.

    DOI: 10.3390/jpm11070668

    Source identity and connection checked by Codex (AI).

  3. Plitidepsin: design, development, and potential place in therapy.

    DOI: 10.2147/dddt.s94165

    Source identity and connection checked by Codex (AI).

  4. Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects.

    DOI: 10.1007/s00280-008-0841-4

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Jimeno J
  • Varona JF
  • Lopez-Martin JA
  • Izquierdo-Useros N
  • Molina Molina E
  • Guisado-Vasco P
  • Sachse M
  • Risco C
  • Losada A
  • Fudio S
  • Luepke E
  • Nieto A
  • Gomez J
  • Aviles P
  • Cuevas C
  • Bouhaddou M
  • Sola I
  • Krogan NJ
  • Enjuanes L
  • Fernandez-Sousa JM
  • GarcÍa-Sastre A
  • White K
  • Alonso-Álvarez S
  • Pardal E
  • Sánchez-Nieto D
  • Navarro M
  • Caballero MD
  • Mateos MV
  • Martín A
  • Nalda-Molina R
  • Valenzuela B
  • Ramon-Lopez A
  • Miguel-Lillo B
  • Soto-Matos A
  • Perez-Ruixo JJ
  • Papapanou M
  • Papoutsi E
  • Giannakas T
  • Katsaounou P